CTLA4 and vulva cancer: TDLN-targeting interventions combining CTLA-4 (in earlier stages) and PD-1 blockade (in later stages) should be considered for vulvar cancer patients, in order to reinvigorate memory T cells and prevent metastatic spread and growth.